Saturday, April 10, 2021 7:03:52 AM
Starting to move now.
. You’ve been ahead of the curve.
Recent CELC News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/02/2026 08:40:20 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/02/2026 08:35:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/02/2026 08:30:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:05:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/31/2026 08:38:38 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 11:30:43 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:10:32 PM
- Celcuity Inc. Reports Release of Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/25/2026 08:01:00 PM
- Celcuity Schedules Release of Fourth Quarter and Full Year 2025 Financial Results and Webcast/Conference Call • GlobeNewswire Inc. • 03/18/2026 12:00:00 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 03/09/2026 11:17:15 PM
- Celcuity Announces Publication of Results from PIK3CA Wild-Type Cohort of Phase 3 VIKTORIA-1 Study of Gedatolisib Regimens in HR+/HER2- Advanced Breast Cancer in Journal of Clinical Oncology • GlobeNewswire Inc. • 03/09/2026 09:42:40 PM
- Celcuity To Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/25/2026 09:01:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/17/2026 02:02:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2026 09:29:32 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2026 09:28:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2026 09:30:28 PM
- Celcuity Appoints Charles Romp to its Board of Directors • GlobeNewswire Inc. • 02/12/2026 09:05:00 PM
- Celcuity to Present at Upcoming Guggenheim Emerging Outlook: Biotech Summit 2026 • GlobeNewswire Inc. • 02/04/2026 12:05:00 PM
- Celcuity Announces FDA Acceptance of New Drug Application for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer • GlobeNewswire Inc. • 01/20/2026 12:30:00 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 01/16/2026 10:30:35 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 01/09/2026 09:30:28 PM
- The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech • GlobeNewswire Inc. • 01/08/2026 05:08:13 PM
- Celcuity Presents Updated Results from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium • GlobeNewswire Inc. • 12/11/2025 07:35:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:23:29 PM
